Sai Life Sciences IPO vs Suraksha Diagnostic IPO

Comparision between Sai Life Sciences IPO and Suraksha Diagnostic IPO.

IPO Details

Sai Life Sciences IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Suraksha Diagnostic IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Sai Life Sciences IPO	Suraksha Diagnostic IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Iifl Securities Ltd Jefferies India Private Limited Morgan Stanley India Company Pvt Ltd	ICICI Securities Limited Nuvama Wealth Management Limited SBI Capital Markets Limited
Registrar	Kfin Technologies Limited	Kfin Technologies Limited
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL		IPO Allotment URL

Issue Size and Price

The total issue size of Sai Life Sciences IPO is up to ₹3,042.62 Cr whereas the issue size of the Suraksha Diagnostic IPO is up to ₹846.25 Cr. The final issue price of Sai Life Sciences IPO is and of Suraksha Diagnostic IPO is ₹441.00 per share.

	Sai Life Sciences IPO	Suraksha Diagnostic IPO
Face Value	₹1 per share	₹2 per share
Issue Price (Lower)	₹522.00 per share	₹420.00 per share
Issue Price (Upper)	₹549.00 per share	₹441.00 per share
Issue Price (Final)		₹441.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	27 shares	34 shares
Fresh Issue Size	1,73,04,189 shares
Fresh Issue Size (Amount)	up to ₹950.00 Cr
OFS Issue Size	3,81,16,934 shares	1,91,89,330 shares
OFS Issue Size (Amount)	up to ₹2,092.62 Cr	up to ₹846.25 Cr
Issue Size Total	5,54,21,123 shares	1,91,89,330 shares
Issue Size Total (Amount)	up to ₹3,042.62 Cr	up to ₹846.25 Cr

IPO Timetable

Sai Life Sciences IPO opens on Dec 11, 2024, while Suraksha Diagnostic IPO opens on Nov 29, 2024. The closing date of Sai Life Sciences IPO and Suraksha Diagnostic IPO is Dec 13, 2024, and Dec 03, 2024, respectively.

	Sai Life Sciences IPO	Suraksha Diagnostic IPO
Anchor Bid Date	Dec 10, 2024	Nov 28, 2024
Issue Open	Dec 11, 2024	Nov 29, 2024
Issue Close	Dec 13, 2024	Dec 03, 2024
Basis Of Allotment (Tentative)	Dec 16, 2024	Dec 04, 2024
Initiation of Refunds (Tentative)	Dec 17, 2024	Dec 05, 2024
Credit of Share (Tentative)	Dec 17, 2024	Dec 05, 2024
Listing date (Tentative)	Dec 18, 2024	Dec 06, 2024
Anchor Lockin End date 1	Jan 15, 2025	Jan 03, 2025
Anchor Lockin End date 2	Mar 16, 2025	Mar 04, 2025

Financials

Sai Life Sciences IPO P/E ratio is 126.42, as compared to Suraksha Diagnostic IPO P/E ratio of 99.31.

Sai Life Sciences IPO

Suraksha Diagnostic IPO

Financial

Sai Life Sciences Limited Financial Information (Restated Consolidated)

Sai Life Sciences Limited's revenue increased by 20% and profit after tax (PAT) rose by 729% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	30 Sep 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	2,476.78	2,275.14	2,186.65	2,164.23
Revenue	693.35	1,494.27	1,245.11	897.74
Profit After Tax	28.01	82.81	9.99	6.23
Net Worth	1,044.75	974.34	887.29	877.76
Reserves and Surplus	1,025.44	953.99	867.43	859.17
Total Borrowing	764.49	710.16	699.23	751.32
Amount in ₹ Crore

Suraksha Diagnostic Limited Financial Information (Restated Consolidated)

Suraksha Diagnostic Limited's revenue increased by 14.75% and profit after tax (PAT) rose by 281.32% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	30 Jun 2024	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	314.20	300.21	281.20	275.96
Revenue	61.85	222.26	193.69	225.77
Profit After Tax	7.67	23.13	6.07	20.82
Net Worth	187.05	179.41	155.93	145.84
Reserves and Surplus	176.80	170.88	147.40	137.31
Total Borrowing	7.57	8.64	14.01	19.03
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

40.48%

61.07%

Promoter Shareholding (Post-Issue)

35.1%

48.78%

P/E Ratio

126.42

99.31

Market Cap

₹11418.63 Cr.

₹2296.76 Cr.

ROE

11.79%%

14.09%%

ROCE

15.96%%

21.46%%

Debt/Equity

0.2

EPS

₹4.34

₹4.44

RoNW

8.13%%

14.09%%

Shares Offered

In the Sai Life Sciences IPO retail investors (RII) are offered 1,93,97,392 shares while in Suraksha Diagnostic IPO retail investors are offered 1,93,97,392 shares. Qualified institutional buyers (QIB) are offered 1,10,84,225 shares in Sai Life Sciences IPO and 38,37,867 shares in Suraksha Diagnostic IPO.

	Sai Life Sciences IPO	Suraksha Diagnostic IPO
Anchor Investor Reserveration	1,66,26,336 shares	57,56,797 shares
Market Maker Reserveration
QIB	1,10,84,225 shares	38,37,867 shares
NII	83,13,168 shares	28,78,400 shares
RII	1,93,97,392 shares	67,16,266 shares
Employee	0 shares	0 shares
Others
Total	3,87,94,785 shares	1,34,32,533 shares

Bids Received (Subscription)

Sai Life Sciences IPO subscribed 1.25x in total, whereas Suraksha Diagnostic IPO subscribed 1.27x.

	Sai Life Sciences IPO	Suraksha Diagnostic IPO
QIB (times)	3.20x	1.74x
NII (times)	0.60x	1.40x
Big NII (times)	0.58x	1.53x
Small NII (times)	0.62x	1.16x
RII (times)	0.42x	0.94x
Employee (times)
Other (times)
Total (times)	1.25x	1.27x

Compare with others

Sai Life Sciences IPO	Suraksha Diagnostic IPO
Indo Farm Equipment IPO	International Gemmological Institute IPO
Transrail Lighting IPO	Mobikwik IPO
International Gemmological Institute IPO	Inventurus Knowledge Solutions IPO
Mobikwik IPO	Sai Life Sciences IPO
Inventurus Knowledge Solutions IPO	Vishal Mega Mart IPO
Vishal Mega Mart IPO	Property Share REIT IPO
Suraksha Diagnostic IPO	Enviro Infra Engineers IPO
Property Share REIT IPO	BlackBuck IPO
Enviro Infra Engineers IPO	Avanse Financial Services IPO
BlackBuck IPO	NTPC Green Energy IPO

Comments

Add a public comment...